Skin cancer Guide

Basal Cell Skin Cancer Section


 


Social bookmarking
You like it? Share it!
socialize it

Newsletter

Subscribe to our newsletter AND receive our exclusive Special Report on Skin-cancer
Name:
Email:



Main Basal Cell Skin Cancer sponsors


 

Latest Basal Cell Skin Cancer Link Added

INSERT YOUR OWN BANNER HERE

Submit your link on Basal Cell Skin Cancer!



 

Welcome to Skin cancer Guide

 

Basal Cell Skin Cancer Article

Thumbnail example. For a permanent link to this article, or to bookmark it for further reading, click here.

Some Information on Basal Cell Skin Cancer

from:

Skin cancer occurs in three forms; basal cell skin cancer, squamous cell skin cancer and melanoma. Of these three, basal cell skin cancer is the most common form of cancer. It is predominant in the US, where about a million new cases are reported every year.
Basal cells are the deepest layer in the epidermis while basal cell carcinomas are malignant growths that grow in this skin layer. This is a form of cancer that seldom metastasizes which results only in scars and disfigurement and seldom is life threatening. It is only if the cancerous cells invade the lymph or blood vessels that this cancer can pass on to the other organs of the body.
Basal call skin cancer is usually spread through local invasion of surrounding skin tissue. This is why the cancer can be cured by the early detection and treatment of the disease. If not treated quickly, basal cell skin cancer proves to be difficult to eliminate and may become large and disturbing.
The risk factors for basal skin cancer are:
• Too much and chronic exposure to the sun over numerous years
• As those with fair or white skin complexion and with blond or red hair are most susceptible to basal skin cancer, a majority of Americans suffer from this skin cancer.
• This cancer was first associated with older people but is now seen more in young adults
With self examination, it is possible to treat basal skin cancer in the bud. Look out for small and pearly nodules that may have telangiectasia on its surface with some ulceration and pigmentation. Even single, flat and depressed lesions that are hard to touch with yellowish or whitish indistinct borders should be referred to the doctor.
A simple biopsy is all that is required to diagnose basal cell carcinoma; and once detected, it is easy to treat. It is only about 5 to 10% of people suffering from basal cell skin cancer who are resistant to treatment, suffer with damage in surrounding skin and at times, may invade the bone and cartilage.
There are different treatment procedures for basal cell skin cancer:
• Curettage where a scalpel is used for scraping malignant tissue and is best for treating superficial carcinoma
• Topical chemotherapy where cancer cells are destroyed by applying pharmacologic agents to the skin
• Cryosurgery where the lesion is destroyed using liquid nitrogen by ultra cold freezing
• Surgical excision is used for removing the cancer when the carcinoma reaches deeper tissues
• Mohs microscopic surgery is the surgical removal of the carcinoma under direct microscopic observation
• Laser surgery where laser beam is used for destroying cancerous tissue
Check with your doctor to choose the best treatment option for your form of basal cell skin cancer.



Other Basal Cell Skin Cancer related Articles

Skin Cancer Pictures
Skin Cancer Treatment
Skin Cancer Moles
Signs Of Skin Cancer
What Is Skin Cancer

Do you want to contribute to our site : submit your articles HERE


 

Basal Cell Skin Cancer News

FDA Approves Erivedge to Treat Most Common Skin Cancer - Basal Cell Carcinoma

Feb. 1, 2012 - Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration this week for the treatment of adults with basal cell carcinoma, the most common type of skin cancer, and should be available in pharmacies within two weeks. Senior citizens are at high risk of these cancers.

Read more...


New drug approved for basal cell carcinoma, most common type of skin cancer

The US Food and Drug Administration approved a new drug today for the most common type of skin cancer, basal cell carcinoma. Erivedge (vismodegib) is the first drug available to treat basal cell cancer that has spread locally or metastasized to distant parts of the body.

Read more...


First Drug Ok'd to Combat Spreading Basal Cell Skin Cancer

MONDAY, Jan. 30 (HealthDay News) -- The U.S. Food and Drug Administration on Monday approved a drug to treat the most common form of skin cancer, basal cell carcinoma.

Read more...


FDA Approves New Skin-Cancer Drug

The U.S. Food and Drug Administration has approved a new type of drug developed by Roche to treat advanced cases of basal cell skin cancer, the most common type of skin cancer.

Read more...


US approves new drug for common skin cancer

US authorities on Monday approved a new drug to treat the most common form of skin cancer, basal cell carcinoma, which is rarely lethal but can spread if left untreated.

Read more...